Loading data for ACON — first visit, this takes a few seconds.
Aclarion Inc. (ACON)
NasdaqCM: ACON
· Precio en tiempo real · USD
2.77
+0.17 (6.54%)
Al cierre: Aug 20, 2026, 10:15 AM
Aclarion Inc. (ACON) Stock Price, Analysis & Data
6.54% (1D)
| Precio de compra | 2 |
| Capitalización de mercado | 7.98M |
| Ingresos (TTM) | 83.77K |
| Beneficio neto (TTM) | -9.2M |
| Beta | 1.22 |
| EPS (TTM) | -7.42 |
| Ratio PER (TTM) | n/a |
| Adelante PE | -0.51 |
| P/B (TTM) | 0.40 |
| P/S (TTM) | 95.31 |
| Earnings Date | n/a |
| Precio de venta | 3.3 |
| Volumen | 124,699 |
| Volumen medio (20D) | 73,087 |
| Abierto | 2.70 |
| Anterior Cerrar | 2.60 |
| Rango del día | 2.53 - 2.79 |
| Rango de 52 semanas | 1.95 - 12.03 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de ACON
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercial...
Industria Health Information Services
Sector Healthcare
IPO Fecha Apr 22, 2022
Empleados 10
Bolsa de Valores NasdaqCM
Símbolo bursátil ACON
Sitio web https://www.aclarion.com
Desempeño financiero
En 2025, los ingresos de Aclarion fueron 75.73K, un aumento de 65.62% en comparación con 45.72K del año anterior. Las ganancias fueron -7.23M, un aumento de 3.44%.
Estados financieros